Navigation Links
Monitoring Receptor-Mediated Changes in [Ca2+]i Using Single-Wavelength and Dual-Wavelength Indicators on the FlexStation Workstation

Simon Lydford & Petra Averbeck, Molecular Devices Limited, U.K.


Introduction
The FlexStation scanning fluorometer integrates sensitive optics, fluid transfer and temperature control, making it ideal for kinetic, cell-based fluorometric assays, such as the measurement of intracellular calcium, membrane potential and intracellular pH.

Calcium (Ca2+) is the most common signal transduction element in cells ranging from bacteria to specialized neurons. Measurement of changes in the concentration of intracellular cations, for example Ca2+, is important in understanding the mechanisms of many cellular processes1. A range of events such as receptor-ligand interactions mediate the elevation of intracellular calcium ([Ca2+]i) levels from ~100nM to ~1mM. This can trigger a number of events, including the release of synaptic transmitters, muscle contraction, hormone secretion, cell movements or apoptosis.

Changes in [Ca2+]i can be measured either with single-wavelength dyes (e.g. Fluo-3 and the FlexStation Calcium Assay Kit) or dual-wavelength ratiometric indicators, such as Fura-2. With single-wavelength dyes the fluorescence intensity is dependent on the Ca2+ concentration whilst ratiometric indicators undergo a spectral shift that is proportional to the Ca2+ concentration. The most common single-wavelength indicators, such as Fluo-3, are excited with visible light and the most common dual-wavelength dyes (Fura-2) require UV light2.

The FlexStation system incorporates a Xenon-lamp light source and dual monochromators that permit the use of essentially all dual-wavelength dyes for functional cellular assays. Although visible-light excitable Ca2+ indicators offer benefits such as reduced interference from sample auto fluorescence and higher absorbance by the dye (permitting the use of lower dye concentrations), ratiometric dyes offer several advantages over conventional single-wavelength indicators:

Benefits of using the 340/380 nm excitation ratios for Fura-2:
Signal is not dependent on:
-Dye concentration
-Illumination intensity
-Optical path length

The effects of uneven dye loading, dye leakage and photo bleaching are minimized
-Detection can usually be made over a period of 1 hour without significant loss of fluorescence

A more stable signal and better signal-to-noise ratio may be obtained
- Increased sensitivity

Accurate measurements of the intracellular Ca2+ concentration is possible

An alternative approach is a series of no-wash reagents available from Molecular Devices, such as the FlexStation Calcium Assay Kit. These, too, confer a number of potential advantages over conventional Ca2+ indicators.

Problems in a conventional assay protocol that may be reduced with no-wash reagents:
Cells removed from the plates during the washing procedure
Reduced responsiveness (competence) of the cells following washing
Variation in the residual volume of wash buffer, leading to variation in the concentration of test compound
The drop in fluorescence (resulting from the dilution of residual extracellular dye) upon addition of the test compound

In this application note we demonstrate the use of both single-wavelength and dual-wavelength Ca2+ indicators in the FlexStation benchtop scanning fluorometer and the possible benefits of a homogeneous assay system.


BACKGROUND
CHO-M1 cells contain endogenous nucleotide receptors (P2Y2)3,4 that are linked to activation of phospholipase C, generation of inositol phosphates (IPs), activation of protein kinase C (PKC) and release of intracellular Ca2+ stores5. Purinoceptors are expressed in the vast majority of cells and tissues, where they control a wide range of physiological processes. To date, five subtypes of the P2Y receptor6 have been identified and clonedP2Y1, P2Y2, P2Y4, P2Y6 and P2Y11. The principal physiological ligands for the P2Y2-receptor are UTP and ATP; they show similar potencies7. One important functional role of the P2Y2-receptor is the control of chloride ion fluxes in airway epithelia and mucociliary clearance in the lung, and thus may play a role in cystic fibrosis and other airway disorders.

Novel ligands targeting P2Y-receptors represent potential therapeutic agents and the ability to screen such compounds reliably and reproducibly has been demonstrated using FlexStation8.

Using Z-factor analysis9 and comparison of EC50 estimates and signal magnitude, we show the benefits of ratiometric Ca2+ dyes and homogeneous assay formats over conventional Ca2+ indicators.


METHODS
Cell Preparation
CHO cells (passage number > 40) were routinely grown in 75 cm2 flasks as a monolayer in Hams-F12 medium supplemented with 10% foetal bovine serum and 5 g/mL G418, and maintained at 37˚C in a CO2 incubator. Cells were passaged 1:10 every 2-3 days.

Measurement of [Ca2+]i
CHO cells were seeded into black-walled, clear-base 96-well plates (Costar UK) at a density of ~30,000 cells per well in Hams-F12 medium, supplemented as above and cultured overnight. The cells were then incubated at 37C for 60 minutes with the appropriate calcium indicator; Fluo-3, Fura-2 or FlexStation Calcium Assay Kit; and 2.5 mM probenecid (see appendix). The cells loaded with Fluo-3 or Fura2 were washed manually (BioHit 8-channel multipipette) three times with Hanks BSS medium containing 2.5 mM probenecid. Cells loaded with the FlexStation Calcium Assay Kit did not require this wash step. The final volume in each well was 200 mL.

The cell plates were then placed into the FlexStation system to monitor fluorescence before and after the addition of ATP (50 ml addition, ATP made at 5X final concentration, final concentrations 30 nm-30 mM). Experimental parameters are tabulated below.


Data Analysis
Responses were measured as peak fluorescence intensity minus basal fluorescence intensity (Fluo-3 or FlexStation calcium reagent) or the 340/380 nm excitation ratios, calculated within SoftMax Pro, for Fura-2. Data are expressed as mean s.e. mean and n > 12.

Individual sets of E/[A] curve data were fitted to a four-parameter logistic of the form:

where α, β, EC50 and m are the asymptote, bottom of curve, location (expressed as -log10 EC50 ) and slope parameters respectively. [A] is the concentration of the agonist where, in this case, its ATP. E is the relative fluorescence units or ratio of fluorescence units for ratiometric dyes. All curve-fitting routines were carried out using GraphPad Prism 3.0 (GraphPad Software, Inc.).

Z-factors were calculated using the formula:


where αc+ denotes standard deviation of the positive control and αc- represents standard deviation of the negative control. The term |c+ c- | denotes the absolute value of the difference between the mean of the positive control and the mean of the negative control. A Z-factor > 0.5 indicates a large separation band between the negative and positive controls and an excellent assay.


RESULTS

ATP elicited a concentration-dependent increase in [Ca2+]i in CHO cells (Figure 1) with similar EC50 values for cells loaded with Fluo-3, Fura-2 and FlexStation Calcium Assay Kit, respectively (Table 2).

One-way Analysis of Variance (ANOVA) indicated that the EC50 estimates were not significantly different from one another (P value = 0.62).


These results indicate that there is negligible difference in the ATP EC50 values from cells loaded with the three fluorescent reagents; however, there was a significant difference between the peak fluorescent intensities of the two single-wavelength indicators. With Fluo-3 there was an increase in signal of ~3,200 RFU above basal (1.8 fold increase) whilst with the FlexStation Calcium Assay Kit the increase in signal was 32,000 RFU (5.6 fold increase, see Table 1). Peak response tended to be more variable with Fluo-3 (see Figure 1). With Fura-2 there was a 4.8 fold increase in signal above basal.

The screening coefficient window (Z-factor), which reflects the dynamic range of the signal and the data variation for the assay9 was calculated using the buffer addition (negative control) and the 30 M ATP addition data (positive control). Z-factors obtained with Fura-2 and the FlexStation Calcium Assay Kit were 0.60 and 0.68 respectively (Table 1). This shows a large separation band between the negative and positive controls and a reproducible, high quality assay. The Zfactor obtained for the Fluo-3 data was 0.28, representing a useable assay. This probably reflects the less than optimal assay protocol and subsequent small dynamic range of the assay.


SUMMARY
In this study, ATP caused a concentration-dependent increase in [Ca2+]i in CHO cells endogenously expressing the P2Y2-receptor, with a potency similar to that reported previously. Furthermore, we have demonstrated that the FlexStation can be used to generate reliable, reproducible data for calcium mobilization assays used to monitor such Gq-coupled GPCRs.

The EC50 estimates for ATP were similar, whether the fluorescent dye Fluo-3 (0.639uM) or Fura-2 (0.639uM) or the FlexStation Calcium Assay Kit (0.651uM) was used, and were consistent between assay plates on the same day, as well as between assays analyzed on different days (less than 0.6 log unit differences). There were, however, significant differences in the dynamic ranges from the three different loading protocols, which is reflected in the corresponding Z-factors. Less than a twofold increase in signal above basal was observed when the cells were loaded with Fluo-3. The most likely cause is the subsequent wash steps in the protocol, reducing cell responsiveness. Using cells of a lower passage number and a dedicated cell-washer (Denley or similar) would probably have improved the Z-factor for Fluo-3 loaded cells. However, under these experimental conditions there was a 5-fold increase in signal observed with Fura-2, despite the cells undergoing a number of wash steps. This could be attributed to the beneficial ratiometric properties of the dye. However, the biggest fold increase in signal and Z-factor was observed with the FlexStation Calcium Assay Kit indicating that this "no-wash", homogeneous assay can lead to stronger signals, higher assay precision and, thus, improved physiological data.

In conclusion, FlexStation provides an easy to use, versatile tool for pharmacological and drug screening laboratories and has proven to be suitable for kinetic, cell-based fluorometric assays, such as the measurement of intracellular calcium. Additionally, FlexStation benefits from the ability to use ratiometric dyes to help improve data fidelity, although the Molecular Devices homogeneous assay kits have been shown to achieve the same goal with fewer steps in the assay.


ACKNOWLEDGEMENTS
Many thanks to Dr. Frank Hafner for his valuable opinion and consulting contribution in this study.


REFERENCES
1. Berridge, M.J. (1997). Elementary and global aspects of calcium signalling. J. Physiol., 499, 291 - 306.

2. Haughland, R.P. (2000). Molecular Probes Handbook of Fluorescent Probes and Research Chemicals. Chapter 20 - Indicators for Ca2+, Mg2+, Zn2+ and Other Metal Ions.

3. Endogenous GPCR List by Agi Schonbrunn, Ph.D. Department of Integrative Biology, Pharmacology and Physiology, University of Texas Health Science Center, Houston, Texas. (http://www.tumor-gene.org/GPCR/gpcr.html)

4. Strassheim, D. and Williams, C.L. (2000). P2Y2 Purinergic and M3 Muscarinic Acetylcholine Receptors Activate Different Phospholipase C- Isoforms That Are Uniquely Susceptible to Protein Kinase C-dependent Phosphorylation and Inactivation. J. Biol. Chem., 275, 39767-39772.

5. Conant, A.R. et al (1998). Characterization of the P2 receptors on the human umbilical vein endothelial cell line ECV304. Br. J. Pharmacol., 125, 357-364.

6. Communi, D., Robaye, B. & Boeynaems, J.M. (1999). Pharmacological characterization of the human P2Y11 receptor. Br. J. Pharmacol., 128, 1199-1206.

7. Law, C., Lydford, S.J. & Henderson, D.J. (1998). Characterisation of the P2receptor(s) on ECV304 endothelial cells using FLIPR. Naunyn-Schmeidebergs Arch.Pharmacol. 358, R126.

8. Zambon, A.C., Conklin, B.R., Brunton, L.L., Insel, P.A. & Ferguson, A.T. (2001). Application Note #1. Gq Protein Coupled Receptor Assays Using FlexStation. (http://www.moleculardevices.com/pdfs/flexstation_1.pdf).

9. Zhang, J-H., Thomas, T.D.Y. and Oldenburg, K. R. (1999). A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screening, 4, 6773.


APPENDIX
Materials
Cells : CHO cells (M1-WT3) - adherent Chinese Hamster Ovary cells stably expressing the rM1-muscarinic receptor (ECACC Ref. #: 940822109)

Reagents: FlexStation Calcium Assay Kit (Molecular Devices, cat # R8041), ATP (Adenosine 5'-triphosphate disodium salt, Sigma, cat # A2383), probenecid (Sigma, cat # P8761), DMSO, low water content (Sigma, cat # D2650), Fluo-3 AM ester (Molecular Probes, cat # F1242), Fura-2 AM ester (Molecular Probes, cat # F1221) and 20% pluronic acid solution (Molecular Probes, cat # P3000)

Plasticware : 75cm2 culture flasks (Corning cat # 430641), 96-well black walled, clear bottomed plates (Costar, cat # 3603), 96-well clear, U-bottom polypropylene plates (Greiner Bio-One, cat # 650101), Pipette tips for FlexStation - 200 L non-sterile, polypropylene tips (Molecular Devices, black cat # 9000-0622 or clear cat # 9000-0623)

Media and buffers : Hams-F12 medium (Invitrogen Life Technologies, cat # 31765-027), Hank's Balanced Salt Solution (HBSS) (10X) (Invitrogen Life Technologies, cat # 14065-049), HEPES 1M buffer solution (Invitrogen Life Technologies, cat # 15630-056), FBS: (Fetal Bovine Serum, heat inactivated, Invitrogen Life Technologies, cat # 10099-141), Geneticin (G418, Invitrogen Life Technologies, cat # 10131-019).


Fluo-3 and Fura-2 reagent preparation
Step 1 Wash buffer: this buffer contains a final concentration of 1X HBSS and 20 mM HEPES diluted in sterile d.H2O. Important: To prevent dye extrusion by the anion exchange protein, the wash buffer is supplemented with 2.5 mM probenecid.

Step 2 Prepare a fresh stock of 250 mM probenecid. Dissolve 710 mg probenecid in 5 mL of 1 M NaOH then add 5 mL of wash buffer and agitate vigorously.

Step 3 Fluo-3 and Fura-2 stock solutions. Add 25 L DMSO to 50 mg Fluo-3 AM or Fura-2 AM (final concentration ~2 mM).

Step 4 Dye loading buffer. Mix 25 L Fluo-3 or Fura-2 stock solutions and 25 L 20% pluronic acid solution, add this to 12 mL wash buffer containing 2.5 mM probenecid then add 120 L FBS. This prepares enough reagent for approximately one 96-well plate. Pluronic acid is used to enhance dye solubility and uptake.


Calcium assay kit reagent preparation
Step 1 Prepare 1X Reagent Buffer using component B and Loading Buffer by diluting component A with 1X Reagent Buffer as described in the instructions provided with the kit

Step 2 Prepare a fresh stock of 250 mM probenecid as above.

Step 3 Add 1:50 dilution of 250 mM probenecid to the Loading Buffer (final concentration 5 mM) and 1:100 dilution of 250 mM probenecid to 1X Reagent Buffer (final concentration 2.5 mM).


back to top


'"/>

Source:


Page: All 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Versatile Reporter Vectors for Monitoring Viral Transduction
2. Monitoring transfection efficiency by green fluorescent protein (GFP) detection with the Agilent 2100 bioanalyzer
3. Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System
4. Monitoring Bacterial Genetic Diversity in a Freshwater Lake Using TTGE and DNA Sequence Analysis
5. Direct Monitoring of Solid-Phase Peptide Synthesis by MALDI-TOF MS
6. Monitoring fluorescence resonance energy transfer (FRET) between GFP fusions in lysates of the yeast Saccharomyces cerevisiae using the Varian Cary Eclipse
7. New statistical algorithms for Monitoring Gene Expression on GeneChip® Probe Arrays
8. Detect Single Nucleotide Sequence Changes with Mx4000 Molecular Beacon Allelic Discrimination Kits
9. Low Abundance cDNA Cloned Using Stratagenes Human Universal cDNA Library
10. Oil-Free PCR Using the Hot Top Assembly
11. Functional Cloning Using ViraPort Retroviral cDNA Expression Libraries
Post Your Comments:
(Date:12/19/2014)... (PRWEB) December 19, 2014 BioPlus ... specialty pharmacies, announces the promotion of Nick Maroulis, Pharm.D. ... Specialty Pharmacy Services. , In this position, Dr. ... while also managing the directors of our multi-site pharmacies ... BioPlus since 1997 and during that time he has ...
(Date:12/19/2014)... BURLINGTON, Mass. , Dec. 19, 2014 ... biomaterial market will grow at a 12 percent compound ... a result of the aging population and the increasing ... Latin America will also spur demand ... results of dental implant and periodontal treatments. ...
(Date:12/19/2014)... MA (PRWEB) December 18, 2014 LayerBio ... for ophthalmology and wound care. The National Eye Institute ... awarded LayerBio a Phase I SBIR grant to develop ... Cataracts are the most common cause of vision loss ... of blindness worldwide. According to Dr. Ken Mandell, LayerBio’s ...
(Date:12/19/2014)... In contrast to traditional LED lights ... colors, Valoya uses proprietary LED technology to incorporate their ... uniformity which is critical in low proximity installations. The ... throughout its lifetime which is up to four times ... "The investment cost was clearly higher when compared to ...
Breaking Biology Technology:BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 3LayerBio Awarded NIH Grant to Develop a Drug Delivery Device for Cataract Surgery 2
... Epeius Biotechnologies ( www.epeiusbiotech.com ) announced today that the U.S. ... anti-cancer agent, Rexin-G , the first, and so far ... out and destroy metastatic cancer. According to Dr. Maria Gordon, ... of clinical development, is that the Rexin-G product, with its ...
... ("ShengdaTech" or the "Company") (NASDAQ: SDTH ), ... China, today announced that Mr. Xiangzhi Chen, the Company,s ... CFO and Mr. A. Carl Mudd, lead independent director, ... Conference to be held from March 6-8, 2011 in ...
... 2011 CSL Behring announces a ... released in conjunction with Rare Disease Day 2011 , ... their impact on people,s lives. The Dialogue spanned ... important information and ideas for patients, caregivers and healthcare providers. ...
Cached Biology Technology:Epeius Biotechnologies' REXIN-G, a Tumor-Targeted Genetic Medicine for Metastatic Cancer, Gains Phase 3 Product Designation From the U.S. FDA 2ShengdaTech to Present at Rodman & Renshaw Annual China Investment Conference in Shanghai 2Thought Leaders in Europe and US Address Challenges to Making Rare Diseases a Global Public Health Priority 2Thought Leaders in Europe and US Address Challenges to Making Rare Diseases a Global Public Health Priority 3Thought Leaders in Europe and US Address Challenges to Making Rare Diseases a Global Public Health Priority 4Thought Leaders in Europe and US Address Challenges to Making Rare Diseases a Global Public Health Priority 5
(Date:12/17/2014)... , Dec. 16, 2014  Automation is ... this more evident than at international borders. Over ... document scanners have allowed veteran travelers to self ... Passport Control (APC) Kiosks at an increasing number ... globe. According to Maxine ...
(Date:12/11/2014)... N.C. , Dec. 10, 2014  That blood pressure ... quite a while. Hypertension – the medical term for high ... the early 1800s, and the inflatable cuff that,s used in ... doesn,t, however, mean there,s nothing new about hypertension, its triggers ... long-held beliefs about the condition and the best ways to ...
(Date:12/10/2014)... 9, 2014  Wake Forest Baptist Medical Center today announced ... School of Medicine. Funding for this $50 million capital ... will be publicly launched next summer. ... former 60 series R.J. Reynolds Tobacco Company complex, adjacent ... begin immediately with plans to be ready to welcome ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
... and, new research shows, an infrared laser can make a ... and Vanderbilt University found that pulsed light can pace contractions ... the tissue. The work, "Optical pacing of the embryonic heart," ... Nature Photonics on Aug. 15, 2010. According to ...
... 27 BIO-key International, Inc. (OTC Bulletin Board: http://photos.prnewswire.com/prnh/20050509/BIOKEYLOGO ) ... What: , BIO-key International, Inc. Second Quarter ... Thursday, July 29, 2010 - 10:00 a.m. Eastern Time ... Live via phone by dialing 800-860-2442 and asking for the BIO-key call ...
... 13, 2010The easy accessibility of the eye and the ... offer hope for using gene therapy to provide long-term ... Human Gene Therapy, a peer-reviewed journal published by Mary ... replacement of a human gene to preserve photoreceptor function ...
Cached Biology News:A heart beats to a different drummer 2BIO-key® Announces Second Quarter 2010 Earnings Release and Conference Call Schedule 2BIO-key® Announces Second Quarter 2010 Earnings Release and Conference Call Schedule 3Promising results of gene therapy to treat diseases of the eye 2
...
A camera based compact unit for high speed scanning of 2D barcoded tubes in a cluster rack. This reader has been designed to read both 96 and 48 tube rack configurations and be compatible with common...
...
... enzyme that catalyzes the conversion,of starch ... maltotriose and,dextrins. The level of a-amylase ... are of clinical importance,1-3 while plant ... industry.4, The EnzChek Amylase Assay Kit ...
Biology Products: